This is a Validated Antibody Database (VAD) review about mouse Adk, based on 3 published articles (read how Labome selects the articles), using Adk antibody in all methods. It is aimed to help Labome visitors find the most suited Adk antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Adk synonym: 2310026J05Rik; 5033405D03Rik; AI255373; AI987814; adenosine kinase; adenosine 5'-phosphotransferase

Santa Cruz Biotechnology
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology Adk antibody (Santa Cruz, sc-365470) was used in western blot on human samples (fig 5a). J Clin Invest (2017) ncbi
Abcam
rabbit polyclonal
  • western blot; mouse; 1:500
Abcam Adk antibody (Abcam, ab88903) was used in western blot on mouse samples at 1:500. FASEB J (2015) ncbi
Invitrogen
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:50; fig 2
  • western blot; human; 1:1000; fig 5
In order to study adenosine deaminase and adenosine kinase expression in human glioma and to determine its correlation with glioma associated epilepsy, Invitrogen Adk antibody (AlbaNova University Center, PA5-13860) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2) and in western blot on human samples at 1:1000 (fig 5). Mol Med Rep (2015) ncbi
Articles Reviewed
  1. Nayar U, Sadek J, Reichel J, Hernandez Hopkins D, Akar G, Barelli P, et al. Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies. J Clin Invest. 2017;127:2066-2080 pubmed publisher
  2. Huang J, He Y, Chen M, Du J, Li G, Li S, et al. Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with glioma‑associated epilepsy. Mol Med Rep. 2015;12:6509-16 pubmed publisher
  3. Martínez Vega R, Garrido F, Partearroyo T, Cediel R, Zeisel S, Martínez Álvarez C, et al. Folic acid deficiency induces premature hearing loss through mechanisms involving cochlear oxidative stress and impairment of homocysteine metabolism. FASEB J. 2015;29:418-32 pubmed publisher